Skip to Main Content

Paper Details

Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
PLoS One
9
2021
4-IPP, 4-iodo-6-phenylpyrimidine, Cancer, D-dopachrome, D-dopachrome tautomerase, DDT, GBM, GSC, GSCs, MAPK, MIF, Macrophage migration inhibitory factor, NF-B, Olig2, PI3K, SOX2, TGM2, cancer, cancer stem cell, glioblastoma multiforme, glioma, macrophage migration inhibitory factor, mesenchymal, pAKT, pERK, proneural, proneural glioma stem cells, stemness, tumor
Author NameAffiliation
Sung Soo KimResearch Institute and Hospital, National Cancer Center
Sung Soo KimGraduate School of Cancer Science and Policy R&D Foundation, National Cancer Center
Sung Soo KimResearch Institute and Hospital, National Cancer Center
Sung Soo KimGraduate School of Cancer Science and Policy R&D Foundation, National Cancer Center
Jong Bae ParkNational Cancer Center
Jong Bae ParkResearch Institute and Hospital, National Cancer Center
  • 1 - 6

Datasets

Release 1.2